Stanford researchers develop mice with human brain tissue to study neurological disorders
Scientists at Stanford have implanted human neurons into mice, creating chimeric brains that comprise up to half the volume, to model conditions such as schizophrenia and cerebral palsy.
Stanford Medicine researchers have engineered mice whose brains contain human neuronal tissue that can occupy up to 50% of the brain by volume. The chimeric animals are intended to serve as live models for complex neurological disorders that are difficult to study in humans.
The team, led by Professor Sergiu Pașca, reprogrammed skin cells from patients into neural precursors, injected roughly 100,000 cells into newborn mice lacking a cerebral cortex and hippocampus, and allowed the tissue to mature for three months. By that time the grafts had integrated with the mouse circulatory system and formed about four million human neurons, some of which connected with mouse brain cells and the spinal cord. The transplanted tissue remained developmentally immature, comparable to a mid-gestation human fetal brain, and did not produce measurable cognitive gains, although the mice showed modest improvements in gait and memory tasks.
To demonstrate the model’s utility, the scientists exposed a subset of the mice to low-oxygen conditions for five hours, mimicking prenatal hypoxia that can lead to cerebral palsy. The human neurons displayed heightened sensitivity to the oxygen deprivation. The researchers also identified von Economo neurons in the grafts, a cell type previously observed only in post-mortem human brains and implicated in frontotemporal dementia, which they plan to investigate further.
“These animal models offer a unique opportunity to study how disease-associated alterations in human brain circuitry manifest in an intact nervous system,” Pașca said in a Stanford Medicine statement.
The work has been conducted under institutional ethical oversight and follows International Society for Stem Cell Research guidelines, with donor consent for the use of human cells. Bioethicists, including members of the UK’s Nuffield Council on Bioethics, have called for continued monitoring of animal welfare and ethical considerations surrounding the integration of human brain tissue in rodents.
Critics note that while in-vivo models provide vascularization and physiological context, the artificial environment of a mouse cavity may not fully recapitulate natural human brain development, and some scientists advocate for organoid-only approaches to reduce animal use.